Literature DB >> 27078821

Colorectal Cancer Screening in a Nationwide High-deductible Health Plan Before and After the Affordable Care Act.

J Frank Wharam1, Fang Zhang, Bruce E Landon, Robert LeCates, Stephen Soumerai, Dennis Ross-Degnan.   

Abstract

BACKGROUND: Little is known about the effect of the Affordable Care Act's (ACA) elimination of out-of-pocket costs for preventive services. This policy likely reduced out-of-pocket colonoscopy costs most for high-deductible health plan (HDHP) members.
OBJECTIVES: Determine the ACA's impact on colorectal cancer screening among HDHP members. RESEARCH
DESIGN: Pre-post with comparison group, constructed before and after the ACA.
SUBJECTS: We studied 2003-2012 administrative claims data of a large national health insurer. HDHP members had 1 year of low-deductible (≤$500) plan enrollment followed by 1 year of HDHP (≥$1000) enrollment after an employer-mandated switch; HDHP enrollment occurred fully after the ACA for 21,605 members and fully before the ACA for 106,609 members. We propensity score-matched contemporaneous low-deductible (≤$500) control group members to both the before-ACA and after-ACA HDHP groups. We examined the 1-year impact of the HDHP switch separately in the before-ACA and after-ACA study cohorts, then compared these changes to estimate ACA effects. MEASURES: Overall colorectal cancer screening, colonoscopy, and fecal-occult blood testing annual rates.
RESULTS: Before the ACA, colorectal cancer screening tests declined by 37/10,000 (-71, -4) among HDHP members versus controls; after the ACA, HDHP members experienced a nonsignificant increase in screening [+52/10,000 (-19,124)]. Corresponding changes in colonoscopy were -55/10,000 (-81, -29) before and +20/10,000 (-38, 78) after the ACA. Thus, the ACA was associated with increased colorectal cancer screening rates [+89/10,000 (11, 168); relative: +9.1% (0.5-17.8)] and screening colonoscopies [+75/10,000 (12-139); relative: +16.4% (2.5-30.3)] among HDHP members.
CONCLUSION: The ACA was associated with improved colorectal cancer screening among HDHP members.

Entities:  

Mesh:

Year:  2016        PMID: 27078821     DOI: 10.1097/MLR.0000000000000521

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  22 in total

1.  The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the United States.

Authors:  Kelsey L Corrigan; Leticia Nogueira; K Robin Yabroff; Chun Chieh Lin; Xuesong Han; Junzo P Chino; Anna E Coghill; Meredith Shiels; Ahmedin Jemal; Gita Suneja
Journal:  Cancer       Date:  2019-11-11       Impact factor: 6.860

2.  Vulnerable And Less Vulnerable Women In High-Deductible Health Plans Experienced Delayed Breast Cancer Care.

Authors:  J Frank Wharam; Fang Zhang; Jamie Wallace; Christine Lu; Craig Earle; Stephen B Soumerai; Larissa Nekhlyudov; Dennis Ross-Degnan
Journal:  Health Aff (Millwood)       Date:  2019-03       Impact factor: 6.301

3.  Cancer preventive services, socioeconomic status, and the Affordable Care Act.

Authors:  Gregory S Cooper; Tzuyung Doug Kou; Avi Dor; Siran M Koroukian; Mark D Schluchter
Journal:  Cancer       Date:  2017-01-09       Impact factor: 6.860

4.  Impact of the Affordable Care Act on Colorectal Cancer Outcomes: A Systematic Review.

Authors:  Michelle R Xu; Amanda M B Kelly; Lawrence H Kushi; Mary E Reed; Howard K Koh; Donna Spiegelman
Journal:  Am J Prev Med       Date:  2020-01-31       Impact factor: 5.043

5.  Value Of Waiving Coinsurance For Colorectal Cancer Screening In Medicare Beneficiaries.

Authors:  Elisabeth F P Peterse; Reinier G S Meester; Andrea Gini; Chyke A Doubeni; Daniel S Anderson; Franklin G Berger; Ann G Zauber; Iris Lansdorp-Vogelaar
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

6.  The ACA and Cancer Screening and Diagnosis.

Authors:  Lindsay M Sabik; Georges Adunlin
Journal:  Cancer J       Date:  2017 May/Jun       Impact factor: 3.360

7.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

Authors:  Janet S de Moor; Robin A Cohen; Jean A Shapiro; Marion R Nadel; Susan A Sabatino; K Robin Yabroff; Stacey Fedewa; Richard Lee; V Paul Doria-Rose; Cheryl Altice; Carrie N Klabunde
Journal:  Prev Med       Date:  2018-05-03       Impact factor: 4.018

8.  Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.

Authors:  Christine Y Lu; Fang Zhang; Anita K Wagner; Larissa Nekhlyudov; Craig C Earle; Matthew Callahan; Robert LeCates; Xin Xu; Dennis Ross-Degnan; J Frank Wharam
Journal:  Breast Cancer Res Treat       Date:  2018-05-12       Impact factor: 4.872

9.  High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes.

Authors:  J Frank Wharam; Christine Y Lu; Fang Zhang; Matthew Callahan; Xin Xu; Jamie Wallace; Stephen Soumerai; Dennis Ross-Degnan; Joseph P Newhouse
Journal:  Ann Intern Med       Date:  2018-11-20       Impact factor: 25.391

10.  Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.

Authors:  J Frank Wharam; Fang Zhang; Christine Y Lu; Anita K Wagner; Larissa Nekhlyudov; Craig C Earle; Stephen B Soumerai; Dennis Ross-Degnan
Journal:  J Clin Oncol       Date:  2018-02-28       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.